Clinical trial
Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
NCT00176202 · University of Illinois at Chicago, Other · Completed
Key facts
| NCT number | NCT00176202 |
|---|---|
| Title | Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar |
| Official title | Controlled Trial of Risperidone and Divalproex Sodium With MRI Assessment of Affected Circuitry in Pre and Post Treatment in Pediatric Bipolar |
| Lead sponsor | University of Illinois at Chicago, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Divalproex Sodium, risperidone |
| Enrollment | 65 |
| Start date | Apr 1, 2003 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 5, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: